Physician profile
Rose James
NPI 1891171153
$5,938.45
in general payments reported to CMS, 2019-2025
24 companies · $676 in 2025
The $676 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $220 · 2021: $937 · 2022: $910 · 2023: $1,420 · 2024: $1,150 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,492 · Travel and Lodging: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,492.43 |
| Travel and Lodging | $752.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,058.88 | 2021-2025 | |
| Anika Therapeutics, INC. | $752.80 | 2023 | Fna Products |
| Biotissue Holdings INC. | $541.11 | 2024 | |
| Organogenesis INC. | $456.11 | 2019-2024 | Puraply |
| Stryker Corporation | $370.47 | 2019-2024 | Salvation, Asnis, Prostep |
| Averitas Pharma INC. | $209.75 | 2023-2025 | Qutenza |
| Convatec INC. | $207.61 | 2023-2024 | |
| Nevro Corp. | $193.20 | 2022-2023 | Senza |
| Smith+Nephew, INC. | $165.25 | 2019 | |
| Paragon 28, INC. | $152.06 | 2019-2024 | Joust Beaming |
| Horizon Therapeutics Plc | $145.17 | 2019-2023 | Krystexxa |
| Triad Life Sciences INC. | $138.56 | 2022 | |
| Paratek Pharmaceuticals, INC. | $130.81 | 2021-2025 | Nuzyra |
| Osiris Therapeutics INC. | $113.13 | 2019 | |
| Zyla Life Sciences, INC. | $61.78 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $47.68 | 2022 | |
| Bioventus LLC | $40.92 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $27.07 | 2023 | Seglentis |
| Amniox Medical, INC. | $24.85 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.06 | 2025 | |
| Depuy Synthes Sales INC. | $22.87 | 2023 | Motoband |
| Normatec Industries, Lp | $21.22 | 2019 | |
| Djo, LLC | $19.78 | 2024 | Cmf |
| Melinta Therapeutics, LLC | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.